Literature DB >> 4979008

Benefits due to immunization against measles.

N W Axnick, S M Shavell, J J Witte.   

Abstract

Mesh：

Year:  1969        PMID： 4979008      PMCID： PMC2031561     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0094-6214            Impact factor:   2.792


× No keyword cloud information.
  5 in total

1.  Propagation in tissue cultures of cytopathogenic agents from patients with measles.

Authors:  J F ENDERS; T C PEEBLES
Journal:  Proc Soc Exp Biol Med       Date:  1954-06

2.  Medical importance of measles.

Authors:  A D LANGMUIR
Journal:  Am J Dis Child       Date:  1962-03

3.  Epidemiologic basis for eradication of measles in 1967.

Authors:  D J Sencer; H B Dull; A D Langmuir
Journal:  Public Health Rep       Date:  1967-03       Impact factor: 2.792

4.  Progress of measles eradication in the United States.

Authors:  H B Dull; J J Witte
Journal:  Public Health Rep       Date:  1968-03       Impact factor: 2.792

5.  Economic cost of St. Louis encephalitis epidemic in Dallas, Texas, 1966.

Authors:  P M Schwab
Journal:  Public Health Rep       Date:  1968-10       Impact factor: 2.792
  5 in total
  12 in total

1.  Setting prices for new vaccines (in advance).

Authors:  Thomas G McGuire
Journal:  Int J Health Care Finance Econ       Date:  2003-09

Review 2.  Pharmacoeconomics of immunisation: a review.

Authors:  R van den Oever; D de Graeve; B Hepp; A Stroobant; D Walckiers; V Van Casteren; F Van Loock; G Ducoffre; J Dewatripont; P Jacques
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

3.  Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza.

Authors:  G M Ginsberg; T H Tulchinsky
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

4.  The economic impact of viral hepatitis in the United States.

Authors:  D D Tolsma; J A Bryan
Journal:  Public Health Rep       Date:  1976 Jul-Aug       Impact factor: 2.792

Review 5.  Recent developments in decision-analytic modelling for economic evaluation.

Authors:  Milton C Weinstein
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  A selected public health bibliography with annotations.

Authors:  C M Wylie
Journal:  Am J Public Health Nations Health       Date:  1970-01

Review 7.  Measles control in developing and developed countries: the case for a two-dose policy.

Authors:  T H Tulchinsky; G M Ginsberg; Y Abed; M T Angeles; C Akukwe; J Bonn
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

8.  Report of the APHA Task Force on Chile.

Authors:  P B Cornely; R Belmar; L A Falk; G L Filerman; H Rodrigues-Trias; V W Sidel; G A Silver; M E Wegman
Journal:  Am J Public Health       Date:  1977-01       Impact factor: 9.308

9.  The benefits from 10 years of measles immunization in the United States.

Authors:  J J Witte; N W Axnick
Journal:  Public Health Rep       Date:  1975 May-Jun       Impact factor: 2.792

10.  Benefits, risks and costs of immunization for measles, mumps and rubella.

Authors:  C C White; J P Koplan; W A Orenstein
Journal:  Am J Public Health       Date:  1985-07       Impact factor: 9.308
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.